Cargando…
Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy
Helper-dependent adenoviral (HDAd) vectors that are devoid of all viral coding sequences are promising non-integrating vectors for gene therapy because they efficiently transduce a variety of cell types in vivo, have a large cloning capacity, and drive long-term transgene expression without chronic...
Autores principales: | Piccolo, Pasquale, Brunetti-Pierri, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423471/ https://www.ncbi.nlm.nih.gov/pubmed/28548064 http://dx.doi.org/10.3390/biomedicines2020132 |
Ejemplares similares
-
Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1
por: Castello, Raffaele, et al.
Publicado: (2015) -
Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013) -
Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy
por: Bandara, Ranmal Avinash, et al.
Publicado: (2021) -
Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives
por: Vetrini, Francesco, et al.
Publicado: (2010) -
Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy
por: Farzad, Lisa M., et al.
Publicado: (2014)